Volume 12 Issue 3
May  2021
Turn off MathJax
Article Contents
Chen Rongxin, Lai Xingqiang, Zhang Lei, et al. Analysis of risk factors and establishment of prediction model for post transplantation diabetes mellitus in renal transplant recipients[J]. ORGAN TRANSPLANTATION, 2021, 12(3): 329-335. doi: 10.3969/j.issn.1674-7445.2021.03.012
Citation: Chen Rongxin, Lai Xingqiang, Zhang Lei, et al. Analysis of risk factors and establishment of prediction model for post transplantation diabetes mellitus in renal transplant recipients[J]. ORGAN TRANSPLANTATION, 2021, 12(3): 329-335. doi: 10.3969/j.issn.1674-7445.2021.03.012

Analysis of risk factors and establishment of prediction model for post transplantation diabetes mellitus in renal transplant recipients

doi: 10.3969/j.issn.1674-7445.2021.03.012
More Information
  • Corresponding author: Chen Zheng, Email: docchenzheng@163.com
  • Received Date: 2021-01-25
    Available Online: 2021-05-19
  • Publish Date: 2021-05-15
  •   Objective  To analyze the risk factors for the occurrence of post transplantation diabetes mellitus (PTDM) in renal transplant recipients, establish a prediction model for PTDM and evaluate its prediction value.  Methods  Clinical data of 915 renal transplant recipients were retrospectively analyzed. According to the occurrence of PTDM, all recipients were divided into the PTDM group (n=78) and non-PTDM group (n=837). The main indexes of recipients were collected. The risk factors for the occurrence of PTDM in renal transplant recipients were analyzed by univariate and multivariate analysis. The prediction model for PTDM was established and its prediction value was evaluated.  Results  Family history of diabetes mellitus, body mass index (BMI), preoperative 2 h postprandial blood glucose and preoperative glycosylated hemoglobin were the independent risk factors for the occurrence of PTDM in renal transplant recipients. The prediction model for PTDM was logit (P)=2.199×family history of diabetes (yes=1, no=0)+0.109×BMI+0.151×2 h postprandial blood glucose (mmol/L)+0.508×glycosylated hemoglobin (%)-9.123. The results of receiver operating characteristic (ROC) curve showed that the area under the curve (AUC) of these 4 predictors combined for predicting PTDM in renal transplant recipients was 0.830 [95% confidence interval (CI) 0.786-0.873], the cut-off value was 0.0608, the sensitivity was 0.821, the specificity was 0.700, and the Youden index was 0.521 (P < 0.05).  Conclusions  Family history of diabetes mellitus, BMI, preoperative 2 h postprandial blood glucose and preoperative glycosylated hemoglobin are the independent risk factors for the occurrence of PTDM in renal transplant recipients. The prediction model for PTDM combined with4 predictors yield relatively high prediction value for PTDM.

     

  • loading
  • [1]
    NAGIB AM, ELSAYED MATTER Y, GHEITH OA, et al. Diabetic nephropathy following posttransplant diabetes mellitus[J]. Exp Clin Transplant, 2019, 17(2): 138-146. DOI: 10.6002/ect.2018.0157.
    [2]
    CIMENO A, MUNLEY J, DRACHENBERG C, et al. Diabetic nephropathy after kidney transplantation in patients with pretransplantation type Ⅱ diabetes: a retrospective case series study from a high-volume center in the United States[J]. Clin Transplant, 2018, 32(12): e13425. DOI: 10.1111/ctr.13425.
    [3]
    DUBOIS-LAFORGUE D. Post-transplantation diabetes mellitus in kidney recipients[J]. Nephrol Ther, 2017, 13(Suppl 1): S137-S146. DOI: 10.1016/j.nephro.2017.01.011.
    [4]
    LIM WH, JOHNSON DW, HAWLEY CM, et al. Impact of diabetes mellitus on the association of vascular disease before transplantation with long-term transplant and patient outcomes after kidney transplantation: a population cohort study[J]. Am J Kidney Dis, 2018, 71(1): 102-111. DOI: 10.1053/j.ajkd.2017.08.018.
    [5]
    CHANG S, JIANG J. Association of body mass index and the risk of new-onset diabetes after kidney transplantation: a Meta-analysis[J]. Transplant Proc, 2018, 50(5): 1316-1325. DOI: 10.1016/j.transproceed.2018.02.075.
    [6]
    GULSOY KIRNAP N, BOZKUS Y, HABERAL M. Analysis of risk factors for posttransplant diabetes mellitus after kidney transplantation: single-center experience[J]. Exp Clin Transplant, 2020, 18(Suppl 1): 36-40. DOI: 10.6002/ect.TOND-TDTD2019.O8.
    [7]
    LORHO R, HARDWIGSEN J, DUMORTIER J, et al. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study[J]. Clin Res Hepatol Gastroenterol, 2011, 35(6/7): 482-488. DOI: 10.1016/j.clinre.2011.03.008.
    [8]
    OKUMI M, UNAGAMI K, HIRAI T, et al. Diabetes mellitus after kidney transplantation in Japanese patients: the Japan Academic Consortium of Kidney Transplantation study[J]. Int J Urol, 2017, 24(3): 197-204. DOI: 10.1111/iju.13253.
    [9]
    CHENG CY, CHEN CH, WU MF, et al. Risk factors in and long-term survival of patients with post-transplantation diabetes mellitus: a retrospective cohort study[J]. Int J Environ Res Public Health, 2020, 17(12): 4581. DOI: 10.3390/ijerph17124581.
    [10]
    GOMES V, FERREIRA F, GUERRA J, et al. New-onset diabetes after kidney transplantation: incidence and associated factors[J]. World J Diabetes, 2018, 9(7): 132-137. DOI: 10.4239/wjd.v9.i7.132.
    [11]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108.

    Branch of Diabetes of Chinese Medical Association. Guidelines for the prevention and control of type 2 diabetes in China (2017 edition)[J]. Chin J Pract Intern Med, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108.
    [12]
    WIESBAUER F, HEINZE G, REGELE H, et al. Glucose control is associated with patient survival in diabetic patients after renal transplantation[J]. Transplantation, 2010, 89(5): 612-619. DOI: 10.1097/TP.0b013e3181c6ffa4.
    [13]
    COSIO FG, PESAVENTO TE, KIM S, et al. Patient survival after renal transplantation: IV. impact of post-transplant diabetes[J]. Kidney Int, 2002, 62(4): 1440-1446. DOI: 10.1111/j.1523-1755.2002.kid582.x.
    [14]
    王周城, 许南炜, 刘宇, 等. 免疫检查点抑制剂介导型糖尿病的研究进展[J]. 实用医学杂志, 2020, 36(18): 2474-2477, 2482. DOI: 10.3969/j.issn.1006-5725.2020. 18.004.

    WANG ZC, XU NW, LIU Y, et al. Research progress on immune checkpoint inhibitor mediated diabetes mellitus[J]. J Pract Med, 2020, 36(18): 2474-2477, 2482. DOI: 10.3969/j.issn.1006-5725.2020.18.004.
    [15]
    SHI D, XIE T, DENG J, et al. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients[J]. Eur J Clin Pharmacol, 2018, 74(6): 723-729. DOI: 10.1007/s00228-018-2442-4.
    [16]
    XU J, XU L, WEI X, et al. Incidence and risk factors of posttransplantation diabetes mellitus in living donor kidney transplantation: a single-center retrospective study in China[J]. Transplant Proc, 2018, 50(10): 3381-3385. DOI: 10.1016/j.transproceed.2018.08.007.
    [17]
    KARCZEWSKI J, ŚLEDZIŃSKA E, BATURO A, et al. Obesity and inflammation[J]. Eur Cytokine Netw, 2018, 29(3): 83-94. DOI: 10.1684/ecn.2018.0415.
    [18]
    ZATTERALE F, LONGO M, NADERI J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J]. Front Physiol, 2020, 10: 1607. DOI: 10.3389/fphys.2019.01607.
    [19]
    WU D, DAWSON NA, LEVINGS MK. Obesity-associated adipose tissue inflammation and transplantation[J]. Am J Transplant, 2016, 16(3): 743-750. DOI: 10.1111/ajt.13578.
    [20]
    GUZMÁN GE, VICTORIA AM, RAMOS I, et al. Risk factors related to new-onset diabetes after renal transplantation in patients of a high complexity University Hospital in Colombia, 20 years of experience[J]. Int J Endocrinol, 2020: 8297192. DOI: 10.1155/2020/8297192.
    [21]
    赖兴强, 张磊, 方佳丽, 等. 肾移植术后新发糖尿病危险因素分析[J]. 中华内分泌外科杂志, 2019, 13(6): 450-455. DOI: 10.3760/cma.j.issn.1674-6090.2019.06.003.

    LAI XQ, ZHANG L, FANG JL, et al. Analysis of risk factors for post-transplant diabetes mellitus in patients with renal transplants[J]. Chin J Endocr Surg, 2019, 13(6): 450-455. DOI: 10.3760/cma.j.issn.1674-6090.2019.06.003.
    [22]
    CASCAIS DE SÁ D, SANTOS L, RODRIGUES L, et al. Post-kidney-transplant diabetes: evaluation of risk factors[J]. Transplant Proc, 2019, 51(5): 1597-1600. DOI: 10.1016/j.transproceed.2019.02.021.
    [23]
    YU H, KIM H, BAEK CH, et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study[J]. BMC Nephrol, 2016, 17(1): 106. DOI: 10.1186/s12882-016-0321-8.
    [24]
    American Diabetes Association. Improving care and promoting health in populations: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43(Suppl 1): S7-S13. DOI: 10.2337/dc20-S001.
    [25]
    BANG JB, OH CK, KIM YS, et al. Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: a multicenter prospective cohort study[J]. Endocrinol Metab (Seoul), 2020, 35(4): 820-829. DOI: 10.3803/EnM.2020.743.
    [26]
    AHMED SH, BIDDLE K, AUGUSTINE T, et al. Post-transplantation diabetes mellitus[J]. Diabetes Ther, 2020, 11(4): 779-801. DOI: 10.1007/s13300-020-00790-5.
    [27]
    WU K, CHENG Y, LI T, et al. The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus[J]. Diabetol Metab Syndr, 2018, 10: 14. DOI: 10.1186/s13098-018-0314-9.
    [28]
    PAEK JH, KANG SS, PARK WY, et al. Incidence of post-transplantation diabetes mellitus within 1 year after kidney transplantation and related factors in Korean cohort study[J]. Transplant Proc, 2019, 51(8): 2714-2717. DOI: 10.1016/j.transproceed.2019.02.054.
    [29]
    CHEWCHARAT A, PRASITLUMKUM N, THONGPRAYOON C, et al. Efficacy and safety of SGLT-2 inhibitors for treatment of diabetes mellitus among kidney transplant patients: a systematic review and Meta-analysis[J]. Med Sci (Basel), 2020, 8(4): 47. DOI: 10.3390/medsci8040047.
    [30]
    TILLMANN FP, RUMP LC, QUACK I. HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation[J]. Int Urol Nephrol, 2018, 50(8): 1529-1534. DOI: 10.1007/s11255-018-1917-7.
    [31]
    ZHENG Y, LEY SH, HU FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98. DOI: 10.1038/nrendo.2017.151.
    [32]
    朱高培, 孙娜, 许小珊, 等. 2型糖尿病风险评估模型和风险评分表的建立[J]. 中国卫生统计, 2019, 36(6): 843-846, 850. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201906010.htm

    ZHU GP, SUN N, XU XS, et al. Establishment of risk assessment model and risk scoretable for type 2 diabetes[J]. Chin J Health Stat, 2019, 36(6): 843-846, 850. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201906010.htm
    [33]
    文江平, 郝洁, 陶丽新, 等. 成年人2型糖尿病风险预测模型的建立[J]. 中华检验医学杂志, 2017, 40(9): 700-706. DOI: 10.3760/cma.j.issn.1009-9158.2017.09.013.

    WEN JP, HAO J, TAO LX, et al. stablishment of the new risk model for prediction of type 2 diabetes[J]. Chin J Lab Med, 2017, 40(9): 700-706. DOI: 10.3760/cma.j.issn.1009-9158.2017.09.013.
    [34]
    王蕾蕾, 潘洁, 曹素艳, 等. 不同糖尿病风险评分在体检人群中应用的效果评价[J]. 中华糖尿病杂志, 2018, 10(2): 123-127. DOI: 10.3760/cma.j.issn.1674-5809.2018.02.007.

    WANG LL, PAN J, CAO SY, et al. Comparison of different diabetic risk score in health check-up population[J]. Chin J Diabetes Mellitus, 2018, 10(2): 123-127. DOI: 10.3760/cma.j.issn.1674-5809.2018.02.007.
    [35]
    宋健, 吴学森, 张杰, 等. 三种统计学模型在糖尿病个体患病风险预测中的应用[J]. 中国卫生统计, 2017, 34(2): 312-314. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201702039.htm

    SONG J, WU XS, ZHANG J, et al. Application of three statistical models in predicting the risk of diabetes individuals[J]. Chin J Health Stat, 2017, 34(2): 312-314. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201702039.htm
    [36]
    陈渝, 宗会娟, 李伟. 2型糖尿病危险因素及患病风险预测模型研究[J]. 昆明理工大学学报(自然科学版), 2018, 43(2): 60-64, 70. DOI: 10.16112/j.cnki.53-1223/n.2018.02.009.

    CHEN Y, ZONG HJ, LI W. A Research on risk factors and risk prediction models of type 2 diabetes mellitus[J]. J Kunming Univ Sci Technol (Nat Sci Edit), 2018, 43(2): 60-64, 70. DOI: 10.16112/j.cnki.53-1223/n.2018.02.009.
    [37]
    马雨佳, 车前子, 郑启文, 等. 2型糖尿病发病风险预测模型常用评价方法[J]. 中国慢性病预防与控制, 2020, 28(2): 94-100. DOI: 10.16386/j.cjpccd.issn.1004-6194.2020.02.004.

    MA YJ, CHE QZ, ZHENG QW, et al. Common evaluation methods of prediction model for risk of type 2 diabetes mellitus[J]. Chin J Prev Contr Chron Dis, 2020, 28(2): 94-100. DOI: 10.16386/j.cjpccd.issn.1004-6194.2020.02.004.
    [38]
    唐慧, 张雪婷, 王翠喆, 等. 中国新疆地区肥胖、糖尿病前期和2型糖尿病检出率及民族分布特征[J]. 实用医学杂志, 2020, 36(10): 1381-1389. DOI:10.3969/j.issn. 1006-5725.2020.10.022.

    TANG H, ZHANG XT, WANG CZ, et al. Detection rates and ethnic group distribution features of obesity, pre-diabetes and T2DM in Xinjiang, China[J]. J Pract Med, 2020, 36(10): 1381-1389. DOI:10.3969/j.issn.1006- 5725.2020.10.022.
    [39]
    MUNSHI VN, SAGHAFIAN S, COOK CB, et al. Incidence, risk factors, and trends for postheart transplantation diabetes mellitus[J]. Am J Cardiol, 2020, 125(3): 436-440. DOI: 10.1016/j.amjcard.2019.10.054.
    [40]
    ZIELIŃSKA K, KUKULSKI L, WRÓBEL M, et al. Prevalence and risk factors of new-onset diabetes after transplantation (NODAT)[J]. Ann Transplant, 2020, 25: e926556. DOI: 10.12659/AOT.926556.
    [41]
    TOMKINS M, TUDOR RM, CRONIN K, et al. Risk factors and long-term consequences of new-onset diabetes after renal transplantation[J]. Ir J Med Sci, 2020, 189(2): 497-503. DOI: 10.1007/s11845-019-02112-6.
    [42]
    JENSSEN T, HARTMANN A. Post-transplant diabetes mellitus in patients with solid organ transplants[J]. Nat Rev Endocrinol, 2019, 15(3): 172-188. DOI: 10.1038/s41574-018-0137-7.
    [43]
    斌荣. SPSS 17.0在医学统计中的应用[M]. 北京: 科学出版社, 2017: 207-219.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (378) PDF downloads(79) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return